{"nctId":"NCT01072201","briefTitle":"To Access the Effects of Mucositis in Adults With Dental Implants","startDateStruct":{"date":"2007-06"},"conditions":["Mucositis"],"count":60,"armGroups":[{"label":"Total toothpaste","type":"EXPERIMENTAL","interventionNames":["Drug: Triclosan and Fluoride"]},{"label":"Ultrabrite toothpaste","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Fluoride"]}],"interventions":[{"name":"Triclosan and Fluoride","otherNames":["Total Toothpaste"]},{"name":"Fluoride","otherNames":["Ultrabrite toothpaste"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female subjects, ages 30-70.\n* Availability for the six-month duration of the clinical research study.\n* Good general health.\n* Subjects who have lost teeth for periodontal disease reasons and who have been restored with implants.\n* Minimum of 5 remaining teeth and a minimum of 2 implants.\n* Initial evaluation of the gingival and peri-implant mucosal tissues by determining full mouth bleeding on probing.\n* Initial plaque evaluation by determining full mouth presence/absence of plaque.\n* Signed Informed Consent Form.\n\nExclusion Criteria:\n\n* Tumor(s) of the soft or hard tissues of the oral cavity.\n* Untreated periodontal disease (purulent exudate, tooth mobility, and/or extensive loss or periodontal attachment or alveolar bone).\n* Carious lesions requiring immediate restorative treatment.\n* Uncontrolled Diabetes\n* Use of antibiotics any time during the one month prior to entry into the study.\n* Untreated peri-implantitis.\n* Participation in any other clinical research study or test panel within the three months prior to entry into the study.\n* Pregnant women or women who are breast feeding.\n* History of allergies to personal care/consumer products or their ingredients.\n* Medical condition which prohibits not eating/drinking for up to 2 hours.\n* Current alcohol or drug abuse.\n* Systemic or local disease conditions that would compromise post-operative healing.\n* Regular use of anti-inflammatory drugs.","healthyVolunteers":true,"sex":"ALL","minimumAge":"30 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Bleeding on Probing","description":"Percentage of Bleeding Scale: The bleeding sites are identified by either a 0 or 1. (0=no bleeding \\& 1= bleeding) The number of spots between teeth that bleed are divided by number of spots between teeth that are scored.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53.8","spread":"17.6"},{"groupId":"OG001","value":"52.3","spread":"24.6"}]}]}]},{"type":"PRIMARY","title":"Mean Pocket Depth","description":"Measurement scale: 0 millimeter measurement= no pocket depth. 3, 4, 5, \\& 6 millimeter are indications of deeper Pocket depth.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":"0.6"},{"groupId":"OG001","value":"4.5","spread":"0.5"}]}]}]},{"type":"PRIMARY","title":"Mean Percentage of Plaque Scores","description":"Mean Percentage (%) of dental plaque on all tooth surfaces, including implants and natural teeth. Plaque Scale is 0=no plaque and 1= dental plaque present. Percentage is derived from sum of all plaque scores divided by the number of tooth surfaces scored.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.2","spread":"15.6"},{"groupId":"OG001","value":"16.0","spread":"17.8"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":[]}}}